EN2 (gene): Difference between revisions

Jump to navigation Jump to search
m (Bot: HTTP→HTTPS)
imported>KolbertBot
m (Bot: HTTP→HTTPS (v485))
 
Line 1: Line 1:
{{Infobox gene}}
{{Infobox gene}}
'''[[Homeobox]] protein [[engrailed (gene)|engrailed]]-2''' is a [[protein]] that in humans is encoded by the ''EN2'' [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: EN2 engrailed homeobox 2| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=2020| accessdate = }}</ref>
'''Homeobox protein engrailed-2''' is a [[protein]] that in humans is encoded by the ''EN2'' [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: EN2 engrailed homeobox 2| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=2020| access-date = }}</ref> It is a member of the [[engrailed (gene)|engrailed]] gene family.


== Function ==
== Function ==
[[Homeobox]]-containing genes are thought to have a role in controlling development. In ''[[Drosophila]]'', the 'engrailed' (en) gene plays an important role during development in segmentation, where it is required for the formation of posterior compartments. Different mutations in the mouse homologs, En1 and En2, produced different developmental defects that frequently are lethal. The human engrailed homologs 1 and 2 encode homeodomain-containing proteins and have been implicated in the control of [[pattern formation]] during development of the central nervous system.<ref name="entrez"/>
[[Homeobox]]-containing genes are thought to have a role in controlling development. In ''[[Drosophila]]'', the 'engrailed' (en) gene plays an important role during development in segmentation, where it is required for the formation of posterior compartments. Different mutations in the mouse homologs, En1 and En2, produced different developmental defects that frequently are lethal. The human engrailed homologs 1 and 2 encode homeodomain-containing proteins and have been implicated in the control of [[pattern formation]] during development of the central nervous system.<ref name="entrez"/>
== Description ==
The Engrailed-2 gene encodes for the Engrailed-2 homeobox transcription factor. The signaling molecule, fibroblast growth factor 8 (FGF8), controls the expression of the En2 gene. The isthmus organizer expresses varying concentrations of FGF8 that influence the En2 transcription factor. En2 transcription factor is involved in patterning the midbrain of the central nervous system during embryonic development. Specifically, it is required for proper positioning of folia in the developing hemispheres. It continues to regulate foliation throughout nervous system development. En2 patterns cerebellum foliation in the mediolateral axis. Several birth defects can arise from inadequate or abnormal En2 expression. Scientists use a mice model to study the effects of En2 knockout alleles on development. When the En2 gene is knocked out, vermis foliation patterning becomes extremely altered. Along with decreased cerebellum foliation complexity, mutations in the En2 gene result in a depleted vermis or an overly simplified foliation pattern. The Engrailed genes are essential to proper neural circuit development.


== In cancer diagnosis ==
== In cancer diagnosis ==
A method for diagnosing [[prostate cancer]] by detection of EN2 in urine has developed. The results of a clinical trial of 288 men suggest that EN2 could be a marker for prostate cancer which might prove more reliable than current methods that use [[prostate-specific antigen]] (PSA). If effective, a urine test is considered easier and less embarrassing for the patient than blood tests or rectal examinations and, therefore, less likely to discourage early diagnosis. At the time of the report, it was not clear whether or not the EN2 test could distinguish between aggressive tumours that would require intervention and relatively benign ones that would not.<ref name="pmid21364037">{{cite journal | vauthors = Morgan R, Boxall A, Bhatt A, Bailey M, Hindley R, Langley S, Whitaker HC, Neal DE, Ismail M, Whitaker H, Annels N, Michael A, Pandha H | title = Engrailed-2 (EN2): a tumor specific urinary biomarker for the early diagnosis of prostate cancer | journal = Clin. Cancer Res. | volume = 17 | issue = 5 | pages = 1090–8 |date=March 2011 | pmid = 21364037 | doi = 10.1158/1078-0432.CCR-10-2410 | laysummary = http://www.bbc.co.uk/news/health-12610972 | laysource = BBC News }}</ref>
A method for diagnosing [[prostate cancer]] by detection of EN2 in urine has been developed. The results of a clinical trial of 288 men suggest that EN2 could be a marker for prostate cancer which might prove more reliable than current methods that use [[prostate-specific antigen]] (PSA). If effective, a urine test is considered easier and less embarrassing for the patient than blood tests or rectal examinations and, therefore, less likely to discourage early diagnosis. At the time of the report, it was not clear whether or not the EN2 test could distinguish between aggressive tumours that would require intervention and relatively benign ones that would not.<ref name="pmid21364037">{{cite journal | vauthors = Morgan R, Boxall A, Bhatt A, Bailey M, Hindley R, Langley S, Whitaker HC, Neal DE, Ismail M, Whitaker H, Annels N, Michael A, Pandha H | title = Engrailed-2 (EN2): a tumor specific urinary biomarker for the early diagnosis of prostate cancer | journal = Clinical Cancer Research | volume = 17 | issue = 5 | pages = 1090–8 | date = March 2011 | pmid = 21364037 | doi = 10.1158/1078-0432.CCR-10-2410 | laysummary = https://www.bbc.co.uk/news/health-12610972 | laysource = BBC News }}</ref>


===Licensing and marketing===
===Licensing and marketing===
The EN2 test for prostate cancer has been licensed to Zeus Scientific, as they reported in March 2013.  In that announcement they said they expected the test to be submitted to the US-FDA in a year,<ref>{{cite web |url=http://www.zeusscientific.com/news-events/news/single/n-action/detail/Item/article/university-of-surrey-licenses-the-patented-use-of-en2-protein-as-a-diagnostic-biomarker-for-prostate-1/ |title=University of Surrey licenses the patented use of EN2 protein as a diagnostic biomarker for prostate and bladder cancer to ZEUS Scientific |date=13 March 2013 }}</ref> and available worldwide in 2 years.<ref>{{cite web |url=http://www.surrey.ac.uk/mediacentre/press/2013/99537_licence_deal_brings_breakthrough_prostate_cancer_test_closer_to_clinical_use.htm |title=Licence deal brings breakthrough prostate cancer test closer to clinical use |date = 13 March 2013 }}</ref>
The EN2 test for prostate cancer has been licensed to Zeus Scientific, as they reported in March 2013.  In that announcement they said they expected the test to be submitted to the US-FDA in a year,<ref>{{cite web |url=http://www.zeusscientific.com/news-events/news/single/n-action/detail/Item/article/university-of-surrey-licenses-the-patented-use-of-en2-protein-as-a-diagnostic-biomarker-for-prostate-1/ |title=University of Surrey licenses the patented use of EN2 protein as a diagnostic biomarker for prostate and bladder cancer to ZEUS Scientific |date=13 March 2013 }}</ref> and available worldwide in 2 years.<ref>{{cite web |url=http://www.surrey.ac.uk/mediacentre/press/2013/99537_licence_deal_brings_breakthrough_prostate_cancer_test_closer_to_clinical_use.htm |title=Licence deal brings breakthrough prostate cancer test closer to clinical use |date = 13 March 2013 }}</ref>


==References==
== References ==
{{reflist}}
{{reflist}}
{{Clear}}
{{Clear}}


==Further reading==
== Further reading ==
{{refbegin | 2}}
{{refbegin | 2}}
*{{cite journal | vauthors=Logan C, Hanks MC, Noble-Topham S |title=Cloning and sequence comparison of the mouse, human, and chicken engrailed genes reveal potential functional domains and regulatory regions. |journal=Dev. Genet. |volume=13 |issue= 5 |pages= 345–58 |year= 1993 |pmid= 1363401 |doi= 10.1002/dvg.1020130505 |display-authors=etal}}
* {{cite journal | vauthors = Cheng Y, Sudarov A, Szulc KU, Sgaier SK, Stephen D, Turnbull DH, Joyner AL | title = The Engrailed homeobox genes determine the different foliation patterns in the vermis and hemispheres of the mammalian cerebellum | journal = Development | volume = 137 | issue = 3 | pages = 519–29 | date = February 2010 | pmid = 20081196 | pmc = 2858911 | doi = 10.1242/dev.027045 }}
*{{cite journal | vauthors=Joyner AL, Herrup K, Auerbach BA |title=Subtle cerebellar phenotype in mice homozygous for a targeted deletion of the En-2 homeobox. |journal=Science |volume=251 |issue= 4998 |pages= 1239–43 |year= 1991 |pmid= 1672471 |doi=10.1126/science.1672471  |display-authors=etal}}
* {{cite journal | vauthors = Logan C, Hanks MC, Noble-Topham S, Nallainathan D, Provart NJ, Joyner AL | title = Cloning and sequence comparison of the mouse, human, and chicken engrailed genes reveal potential functional domains and regulatory regions | journal = Developmental Genetics | volume = 13 | issue = 5 | pages = 345–58 | year = 1993 | pmid = 1363401 | doi = 10.1002/dvg.1020130505 }}
*{{cite journal | vauthors=Poole SJ, Law ML, Kao FT, Lau YF |title=Isolation and chromosomal localization of the human En-2 gene. |journal=Genomics |volume=4 |issue= 3 |pages= 225–31 |year= 1989 |pmid= 2565873 |doi=10.1016/0888-7543(89)90324-8  }}
* {{cite journal | vauthors = Joyner AL, Herrup K, Auerbach BA, Davis CA, Rossant J | title = Subtle cerebellar phenotype in mice homozygous for a targeted deletion of the En-2 homeobox | journal = Science | volume = 251 | issue = 4998 | pages = 1239–43 | date = March 1991 | pmid = 1672471 | doi = 10.1126/science.1672471 }}
*{{cite journal | vauthors=Logan C, Willard HF, Rommens JM, Joyner AL |title=Chromosomal localization of the human homeo box-containing genes, EN1 and EN2. |journal=Genomics |volume=4 |issue= 2 |pages= 206–9 |year= 1989 |pmid= 2567700 |doi=10.1016/0888-7543(89)90301-}}
* {{cite journal | vauthors = Poole SJ, Law ML, Kao FT, Lau YF | title = Isolation and chromosomal localization of the human En-2 gene | journal = Genomics | volume = 4 | issue = 3 | pages = 225–31 | date = April 1989 | pmid = 2565873 | doi = 10.1016/0888-7543(89)90324-8 }}
*{{cite journal | vauthors=Kozmik Z, Sure U, Rüedi D |title=Deregulated expression of PAX5 in medulloblastoma |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=92 |issue= 12 |pages= 5709–13 |year= 1995 |pmid= 7777574 |doi=10.1073/pnas.92.12.5709  | pmc=41766  |display-authors=etal}}
* {{cite journal | vauthors = Logan C, Willard HF, Rommens JM, Joyner AL | title = Chromosomal localization of the human homeo box-containing genes, EN1 and EN2 | journal = Genomics | volume = 4 | issue = 2 | pages = 206–9 | date = February 1989 | pmid = 2567700 | doi = 10.1016/0888-7543(89)90301-7 }}
*{{cite journal | vauthors=Joliot A, Trembleau A, Raposo G |title=Association of Engrailed homeoproteins with vesicles presenting caveolae-like properties |journal=Development |volume=124 |issue= 10 |pages= 1865–75 |year= 1997 |pmid= 9169834 |doi= |display-authors=etal}}
* {{cite journal | vauthors = Kozmik Z, Sure U, Rüedi D, Busslinger M, Aguzzi A | title = Deregulated expression of PAX5 in medulloblastoma | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 92 | issue = 12 | pages = 5709–13 | date = June 1995 | pmid = 7777574 | pmc = 41766 | doi = 10.1073/pnas.92.12.5709 }}
*{{cite journal |title=A full genome screen for autism with evidence for linkage to a region on chromosome 7q. International Molecular Genetic Study of Autism Consortium |journal=Hum. Mol. Genet. |volume=7 |issue= 3 |pages= 571–8 |year= 1998 |pmid= 9546821 |doi=10.1093/hmg/7.3.571 }}
* {{cite journal | vauthors = Joliot A, Trembleau A, Raposo G, Calvet S, Volovitch M, Prochiantz A | title = Association of Engrailed homeoproteins with vesicles presenting caveolae-like properties | journal = Development | volume = 124 | issue = 10 | pages = 1865–75 | date = May 1997 | pmid = 9169834 | doi =  }}
*{{cite journal  |title=Toward a complete human genome sequence |journal=Genome Res. |volume=8 |issue= 11 |pages= 1097–108 |year= 1999 |pmid= 9847074 |doi= 10.1101/gr.8.11.1097}}
* {{cite journal | vauthors = | title = A full genome screen for autism with evidence for linkage to a region on chromosome 7q. International Molecular Genetic Study of Autism Consortium | journal = Human Molecular Genetics | volume = 7 | issue = 3 | pages = 571–8 | date = March 1998 | pmid = 9546821 | doi = 10.1093/hmg/7.3.571 }}
*{{cite journal | vauthors=Philippe A, Martinez M, Guilloud-Bataille M |title=Genome-wide scan for autism susceptibility genes. Paris Autism Research International Sibpair Study |journal=Hum. Mol. Genet. |volume=8 |issue= 5 |pages= 805–12 |year= 1999 |pmid= 10196369 |doi=10.1093/hmg/8.5.805  |display-authors=etal}}
* {{cite journal | vauthors = | title = Toward a complete human genome sequence | journal = Genome Research | volume = 8 | issue = 11 | pages = 1097–108 | date = November 1998 | pmid = 9847074 | doi = 10.1101/gr.8.11.1097 }}
*{{cite journal | vauthors=Risch N, Spiker D, Lotspeich L |title=A genomic screen of autism: evidence for a multilocus etiology |journal=Am. J. Hum. Genet. |volume=65 |issue= 2 |pages= 493–507 |year= 1999 |pmid= 10417292 |doi=10.1086/302497  | pmc=1377948  |display-authors=etal}}
* {{cite journal | vauthors = Philippe A, Martinez M, Guilloud-Bataille M, Gillberg C, Råstam M, Sponheim E, Coleman M, Zappella M, Aschauer H, Van Maldergem L, Penet C, Feingold J, Brice A, Leboyer M, van Malldergerme L | title = Genome-wide scan for autism susceptibility genes. Paris Autism Research International Sibpair Study | journal = Human Molecular Genetics | volume = 8 | issue = 5 | pages = 805–12 | date = May 1999 | pmid = 10196369 | doi = 10.1093/hmg/8.5.805 }}
*{{cite journal | vauthors=Ashley-Koch A, Wolpert CM, Menold MM |title=Genetic studies of autistic disorder and chromosome 7 |journal=Genomics |volume=61 |issue= 3 |pages= 227–36 |year= 2000 |pmid= 10552924 |doi= 10.1006/geno.1999.5968 |display-authors=etal}}
* {{cite journal | vauthors = Risch N, Spiker D, Lotspeich L, Nouri N, Hinds D, Hallmayer J, Kalaydjieva L, McCague P, Dimiceli S, Pitts T, Nguyen L, Yang J, Harper C, Thorpe D, Vermeer S, Young H, Hebert J, Lin A, Ferguson J, Chiotti C, Wiese-Slater S, Rogers T, Salmon B, Nicholas P, Petersen PB, Pingree C, McMahon W, Wong DL, Cavalli-Sforza LL, Kraemer HC, Myers RM | title = A genomic screen of autism: evidence for a multilocus etiology | journal = American Journal of Human Genetics | volume = 65 | issue = 2 | pages = 493–507 | date = August 1999 | pmid = 10417292 | pmc = 1377948 | doi = 10.1086/302497 }}
*{{cite journal  | vauthors=Barrett S, Beck JC, Bernier R |title=An autosomal genomic screen for autism. Collaborative linkage study of autism |journal=Am. J. Med. Genet. |volume=88 |issue= 6 |pages= 609–15 |year= 2000 |pmid= 10581478 |doi=10.1002/(SICI)1096-8628(19991215)88:6<609::AID-AJMG7>3.3.CO;2-C  |display-authors=etal}}
* {{cite journal | vauthors = Ashley-Koch A, Wolpert CM, Menold MM, Zaeem L, Basu S, Donnelly SL, Ravan SA, Powell CM, Qumsiyeh MB, Aylsworth AS, Vance JM, Gilbert JR, Wright HH, Abramson RK, DeLong GR, Cuccaro ML, Pericak-Vance MA | title = Genetic studies of autistic disorder and chromosome 7 | journal = Genomics | volume = 61 | issue = 3 | pages = 227–36 | date = November 1999 | pmid = 10552924 | doi = 10.1006/geno.1999.5968 }}
*{{cite journal  | vauthors=Sarnat HB, Benjamin DR, Siebert JR |title=Agenesis of the mesencephalon and metencephalon with cerebellar hypoplasia: putative mutation in the EN2 gene--report of 2 cases in early infancy |journal=Pediatr. Dev. Pathol. |volume=5 |issue= 1 |pages= 54–68 |year= 2002 |pmid= 11815869 |doi=10.1007/s10024-001-0103-5  |display-authors=etal}}
* {{cite journal | vauthors = Barrett S, Beck JC, Bernier R, Bisson E, Braun TA, Casavant TL, Childress D, Folstein SE, Garcia M, Gardiner MB, Gilman S, Haines JL, Hopkins K, Landa R, Meyer NH, Mullane JA, Nishimura DY, Palmer P, Piven J, Purdy J, Santangelo SL, Searby C, Sheffield V, Singleton J, Slager S | title = An autosomal genomic screen for autism. Collaborative linkage study of autism | journal = American Journal of Medical Genetics | volume = 88 | issue = 6 | pages = 609–15 | date = December 1999 | pmid = 10581478 | doi = 10.1002/(SICI)1096-8628(19991215)88:6<609::AID-AJMG7>3.3.CO;2-C }}
*{{cite journal | vauthors=Zhong H, Serajee FJ, Nabi R, Huq AH |title=No association between the EN2 gene and autistic disorder |journal=J. Med. Genet. |volume=40 |issue= 1 |pages= e4 |year= 2003 |pmid= 12525552 |doi=10.1136/jmg.40.1.e4  | pmc=1735256  }}
* {{cite journal | vauthors = Sarnat HB, Benjamin DR, Siebert JR, Kletter GB, Cheyette SR | title = Agenesis of the mesencephalon and metencephalon with cerebellar hypoplasia: putative mutation in the EN2 gene--report of 2 cases in early infancy | journal = Pediatric and Developmental Pathology | volume = 5 | issue = 1 | pages = 54–68 | year = 2002 | pmid = 11815869 | doi = 10.1007/s10024-001-0103-5 }}
*{{cite journal | vauthors=Foucher I, Montesinos ML, Volovitch M |title=Joint regulation of the MAP1B promoter by HNF3beta/Foxa2 and Engrailed is the result of a highly conserved mechanism for direct interaction of homeoproteins and Fox transcription factors |journal=Development |volume=130 |issue= 9 |pages= 1867–76 |year= 2003 |pmid= 12642491 |doi=10.1242/dev.00414  |display-authors=etal}}
* {{cite journal | vauthors = Zhong H, Serajee FJ, Nabi R, Huq AH | title = No association between the EN2 gene and autistic disorder | journal = Journal of Medical Genetics | volume = 40 | issue = 1 | pages = e4 | date = January 2003 | pmid = 12525552 | pmc = 1735256 | doi = 10.1136/jmg.40.1.e4 }}
*{{cite journal | vauthors=Scherer SW, Cheung J, MacDonald JR |title=Human Chromosome 7: DNA Sequence and Biology |journal=Science |volume=300 |issue= 5620 |pages= 767–72 |year= 2003 |pmid= 12690205 |doi= 10.1126/science.1083423  | pmc=2882961 |display-authors=etal}}
* {{cite journal | vauthors = Foucher I, Montesinos ML, Volovitch M, Prochiantz A, Trembleau A | title = Joint regulation of the MAP1B promoter by HNF3beta/Foxa2 and Engrailed is the result of a highly conserved mechanism for direct interaction of homeoproteins and Fox transcription factors | journal = Development | volume = 130 | issue = 9 | pages = 1867–76 | date = May 2003 | pmid = 12642491 | doi = 10.1242/dev.00414 }}
*{{cite journal | vauthors=Hillier LW, Fulton RS, Fulton LA |title=The DNA sequence of human chromosome 7 |journal=Nature |volume=424 |issue= 6945 |pages= 157–64 |year= 2003 |pmid= 12853948 |doi= 10.1038/nature01782 |display-authors=etal}}
* {{cite journal | vauthors = Gharani N, Benayed R, Mancuso V, Brzustowicz LM, Millonig JH | title = Association of the homeobox transcription factor, ENGRAILED 2, 3, with autism spectrum disorder | journal = Molecular Psychiatry | volume = 9 | issue = 5 | pages = 474–84 | date = May 2004 | pmid = 15024396 | doi = 10.1038/sj.mp.4001498 }}
*{{cite journal | vauthors=Gharani N, Benayed R, Mancuso V |title=Association of the homeobox transcription factor, ENGRAILED 2, 3, with autism spectrum disorder |journal=Mol. Psychiatry |volume=9 |issue= 5 |pages= 474–84 |year= 2004 |pmid= 15024396 |doi= 10.1038/sj.mp.4001498 |display-authors=etal}}
* {{cite journal | vauthors = Hjerrild M, Stensballe A, Rasmussen TE, Kofoed CB, Blom N, Sicheritz-Ponten T, Larsen MR, Brunak S, Jensen ON, Gammeltoft S | title = Identification of phosphorylation sites in protein kinase A substrates using artificial neural networks and mass spectrometry | journal = Journal of Proteome Research | volume = 3 | issue = 3 | pages = 426–33 | year = 2004 | pmid = 15253423 | doi = 10.1021/pr0341033 }}
*{{cite journal | vauthors=Hjerrild M, Stensballe A, Rasmussen TE |title=Identification of phosphorylation sites in protein kinase A substrates using artificial neural networks and mass spectrometry |journal=J. Proteome Res. |volume=3 |issue= 3 |pages= 426–33 |year= 2004 |pmid= 15253423 |doi=10.1021/pr0341033 |display-authors=etal}}
{{refend}}
{{refend}}


Line 47: Line 49:
[[Category:Transcription factors]]
[[Category:Transcription factors]]
[[Category:Prostate cancer]]
[[Category:Prostate cancer]]


{{gene-7-stub}}
{{gene-7-stub}}

Latest revision as of 13:33, 21 July 2018

VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

Homeobox protein engrailed-2 is a protein that in humans is encoded by the EN2 gene.[1] It is a member of the engrailed gene family.

Function

Homeobox-containing genes are thought to have a role in controlling development. In Drosophila, the 'engrailed' (en) gene plays an important role during development in segmentation, where it is required for the formation of posterior compartments. Different mutations in the mouse homologs, En1 and En2, produced different developmental defects that frequently are lethal. The human engrailed homologs 1 and 2 encode homeodomain-containing proteins and have been implicated in the control of pattern formation during development of the central nervous system.[1]

Description

The Engrailed-2 gene encodes for the Engrailed-2 homeobox transcription factor. The signaling molecule, fibroblast growth factor 8 (FGF8), controls the expression of the En2 gene. The isthmus organizer expresses varying concentrations of FGF8 that influence the En2 transcription factor. En2 transcription factor is involved in patterning the midbrain of the central nervous system during embryonic development. Specifically, it is required for proper positioning of folia in the developing hemispheres. It continues to regulate foliation throughout nervous system development. En2 patterns cerebellum foliation in the mediolateral axis. Several birth defects can arise from inadequate or abnormal En2 expression. Scientists use a mice model to study the effects of En2 knockout alleles on development. When the En2 gene is knocked out, vermis foliation patterning becomes extremely altered. Along with decreased cerebellum foliation complexity, mutations in the En2 gene result in a depleted vermis or an overly simplified foliation pattern. The Engrailed genes are essential to proper neural circuit development.

In cancer diagnosis

A method for diagnosing prostate cancer by detection of EN2 in urine has been developed. The results of a clinical trial of 288 men suggest that EN2 could be a marker for prostate cancer which might prove more reliable than current methods that use prostate-specific antigen (PSA). If effective, a urine test is considered easier and less embarrassing for the patient than blood tests or rectal examinations and, therefore, less likely to discourage early diagnosis. At the time of the report, it was not clear whether or not the EN2 test could distinguish between aggressive tumours that would require intervention and relatively benign ones that would not.[2]

Licensing and marketing

The EN2 test for prostate cancer has been licensed to Zeus Scientific, as they reported in March 2013. In that announcement they said they expected the test to be submitted to the US-FDA in a year,[3] and available worldwide in 2 years.[4]

References

  1. 1.0 1.1 "Entrez Gene: EN2 engrailed homeobox 2".
  2. Morgan R, Boxall A, Bhatt A, Bailey M, Hindley R, Langley S, Whitaker HC, Neal DE, Ismail M, Whitaker H, Annels N, Michael A, Pandha H (March 2011). "Engrailed-2 (EN2): a tumor specific urinary biomarker for the early diagnosis of prostate cancer". Clinical Cancer Research. 17 (5): 1090–8. doi:10.1158/1078-0432.CCR-10-2410. PMID 21364037. Lay summaryBBC News.
  3. "University of Surrey licenses the patented use of EN2 protein as a diagnostic biomarker for prostate and bladder cancer to ZEUS Scientific". 13 March 2013.
  4. "Licence deal brings breakthrough prostate cancer test closer to clinical use". 13 March 2013.

Further reading

  • Cheng Y, Sudarov A, Szulc KU, Sgaier SK, Stephen D, Turnbull DH, Joyner AL (February 2010). "The Engrailed homeobox genes determine the different foliation patterns in the vermis and hemispheres of the mammalian cerebellum". Development. 137 (3): 519–29. doi:10.1242/dev.027045. PMC 2858911. PMID 20081196.
  • Logan C, Hanks MC, Noble-Topham S, Nallainathan D, Provart NJ, Joyner AL (1993). "Cloning and sequence comparison of the mouse, human, and chicken engrailed genes reveal potential functional domains and regulatory regions". Developmental Genetics. 13 (5): 345–58. doi:10.1002/dvg.1020130505. PMID 1363401.
  • Joyner AL, Herrup K, Auerbach BA, Davis CA, Rossant J (March 1991). "Subtle cerebellar phenotype in mice homozygous for a targeted deletion of the En-2 homeobox". Science. 251 (4998): 1239–43. doi:10.1126/science.1672471. PMID 1672471.
  • Poole SJ, Law ML, Kao FT, Lau YF (April 1989). "Isolation and chromosomal localization of the human En-2 gene". Genomics. 4 (3): 225–31. doi:10.1016/0888-7543(89)90324-8. PMID 2565873.
  • Logan C, Willard HF, Rommens JM, Joyner AL (February 1989). "Chromosomal localization of the human homeo box-containing genes, EN1 and EN2". Genomics. 4 (2): 206–9. doi:10.1016/0888-7543(89)90301-7. PMID 2567700.
  • Kozmik Z, Sure U, Rüedi D, Busslinger M, Aguzzi A (June 1995). "Deregulated expression of PAX5 in medulloblastoma". Proceedings of the National Academy of Sciences of the United States of America. 92 (12): 5709–13. doi:10.1073/pnas.92.12.5709. PMC 41766. PMID 7777574.
  • Joliot A, Trembleau A, Raposo G, Calvet S, Volovitch M, Prochiantz A (May 1997). "Association of Engrailed homeoproteins with vesicles presenting caveolae-like properties". Development. 124 (10): 1865–75. PMID 9169834.
  • "A full genome screen for autism with evidence for linkage to a region on chromosome 7q. International Molecular Genetic Study of Autism Consortium". Human Molecular Genetics. 7 (3): 571–8. March 1998. doi:10.1093/hmg/7.3.571. PMID 9546821.
  • "Toward a complete human genome sequence". Genome Research. 8 (11): 1097–108. November 1998. doi:10.1101/gr.8.11.1097. PMID 9847074.
  • Philippe A, Martinez M, Guilloud-Bataille M, Gillberg C, Råstam M, Sponheim E, Coleman M, Zappella M, Aschauer H, Van Maldergem L, Penet C, Feingold J, Brice A, Leboyer M, van Malldergerme L (May 1999). "Genome-wide scan for autism susceptibility genes. Paris Autism Research International Sibpair Study". Human Molecular Genetics. 8 (5): 805–12. doi:10.1093/hmg/8.5.805. PMID 10196369.
  • Risch N, Spiker D, Lotspeich L, Nouri N, Hinds D, Hallmayer J, Kalaydjieva L, McCague P, Dimiceli S, Pitts T, Nguyen L, Yang J, Harper C, Thorpe D, Vermeer S, Young H, Hebert J, Lin A, Ferguson J, Chiotti C, Wiese-Slater S, Rogers T, Salmon B, Nicholas P, Petersen PB, Pingree C, McMahon W, Wong DL, Cavalli-Sforza LL, Kraemer HC, Myers RM (August 1999). "A genomic screen of autism: evidence for a multilocus etiology". American Journal of Human Genetics. 65 (2): 493–507. doi:10.1086/302497. PMC 1377948. PMID 10417292.
  • Ashley-Koch A, Wolpert CM, Menold MM, Zaeem L, Basu S, Donnelly SL, Ravan SA, Powell CM, Qumsiyeh MB, Aylsworth AS, Vance JM, Gilbert JR, Wright HH, Abramson RK, DeLong GR, Cuccaro ML, Pericak-Vance MA (November 1999). "Genetic studies of autistic disorder and chromosome 7". Genomics. 61 (3): 227–36. doi:10.1006/geno.1999.5968. PMID 10552924.
  • Barrett S, Beck JC, Bernier R, Bisson E, Braun TA, Casavant TL, Childress D, Folstein SE, Garcia M, Gardiner MB, Gilman S, Haines JL, Hopkins K, Landa R, Meyer NH, Mullane JA, Nishimura DY, Palmer P, Piven J, Purdy J, Santangelo SL, Searby C, Sheffield V, Singleton J, Slager S (December 1999). "An autosomal genomic screen for autism. Collaborative linkage study of autism". American Journal of Medical Genetics. 88 (6): 609–15. doi:10.1002/(SICI)1096-8628(19991215)88:6<609::AID-AJMG7>3.3.CO;2-C. PMID 10581478.
  • Sarnat HB, Benjamin DR, Siebert JR, Kletter GB, Cheyette SR (2002). "Agenesis of the mesencephalon and metencephalon with cerebellar hypoplasia: putative mutation in the EN2 gene--report of 2 cases in early infancy". Pediatric and Developmental Pathology. 5 (1): 54–68. doi:10.1007/s10024-001-0103-5. PMID 11815869.
  • Zhong H, Serajee FJ, Nabi R, Huq AH (January 2003). "No association between the EN2 gene and autistic disorder". Journal of Medical Genetics. 40 (1): e4. doi:10.1136/jmg.40.1.e4. PMC 1735256. PMID 12525552.
  • Foucher I, Montesinos ML, Volovitch M, Prochiantz A, Trembleau A (May 2003). "Joint regulation of the MAP1B promoter by HNF3beta/Foxa2 and Engrailed is the result of a highly conserved mechanism for direct interaction of homeoproteins and Fox transcription factors". Development. 130 (9): 1867–76. doi:10.1242/dev.00414. PMID 12642491.
  • Gharani N, Benayed R, Mancuso V, Brzustowicz LM, Millonig JH (May 2004). "Association of the homeobox transcription factor, ENGRAILED 2, 3, with autism spectrum disorder". Molecular Psychiatry. 9 (5): 474–84. doi:10.1038/sj.mp.4001498. PMID 15024396.
  • Hjerrild M, Stensballe A, Rasmussen TE, Kofoed CB, Blom N, Sicheritz-Ponten T, Larsen MR, Brunak S, Jensen ON, Gammeltoft S (2004). "Identification of phosphorylation sites in protein kinase A substrates using artificial neural networks and mass spectrometry". Journal of Proteome Research. 3 (3): 426–33. doi:10.1021/pr0341033. PMID 15253423.

External links

This article incorporates text from the United States National Library of Medicine, which is in the public domain.